Skip to content

Covid-19-associated research on hand eczema in the health sector – Part 2

Covid-19-associated research on hand eczema in the health sector – Part 2 - CARE+

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00022958
Enrollment
35
Registered
2020-10-07
Start date
2021-01-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L20-L30

Interventions

Group 1: The study is thematically divided into 2 study sections/study weeks, which will take place during the winter months of 2021. In the first study week (1 appointment) the effect of the washing
the concentrations of NMF, the cytokines interleukin-1-alpha (IL-1a) and interleukin-1 receptor antagonist (IL-1RA) are determined by tape stripping on the left and right volar forearm and upper arm a

Sponsors

Institut für interdisziplinäre dermatologische Prävention und Rehabilitation an der Universität Osnabrück (iDerm)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: - Presence of a signed declaration of consent - Skin type I-III according to Fitzpatrick - Willingness to participate in all study dates - clinically healthy and untreated skin on the volar forearms, upper arms and hands - Readiness to use no cosmetic cleansing and care products at the test sites on the volar forearm and upper arm 24 hours before participation in the study and during the study - Willingness to refrain from using hair removal treatments (depilation, epilation) at the test sites on the volar forearm and upper arm from 1 week prior to the study start and during the study phase - Willingness to not expose the test sites on the volar forearm and upper arm to intensive UV radiation (sunbathing / solarium) 6 weeks before the start of the study and during the study phase

Exclusion criteria

Exclusion criteria: - Erlanger Atopy score > 8 - known allergy to fragrances or oatmeal - body modification (tattoos, piercings, transdermals, scarification, etc.) in the test areas - excessive hair in test areas - application of so-called self-tanning preparations in test areas - taking immunosuppressive medication (e.g. cortisone) - application of medical, anti-inflammatory preparations (e.g. cortisone cream) in the test areas in the last 7 days before the practical study phase - pregnancy or lactation

Design outcomes

Primary

MeasureTime frame
Increased attention regarding the effects of increased hand washing duration and frequency on epidermal barrier function and induction of inflammatory processes in the epidermis. Recording of the duration of hand washing (study section I) is carried out at the following points in time for the parameters listed below: T0 (zero survey) T1 (15 minutes after skin cleansing) T2 (60 minutes after skin cleansing) parameter: TEWL, RHF, a* value, pH The frequency of skin cleansing (study section II) is recorded at the following points in time: T0 (zero survey) T1 (15 minutes after last wash) T2 (60 minutes after last wash) T3 (24 hours after last wash Parameter T0-T3: TEWL, RHF, a* value, pH (test field 1-8) Only at T3: Tape stripping (D-Squame®) for the determination of Natural Moisturizing Factor (NMF) and cytokines (IL-1a & IL-1aRA) additionally NMF determination by confocal Raman spectroscopy (NMF scan).

Secondary

MeasureTime frame
Development of scientifically based recommendations regarding the optimization of skin protection and skin care.

Countries

Germany

Contacts

Public ContactCara Symanzik

Institut für interdisziplinäre dermatologische Prävention und Rehabilitation an der Universität Osnabrück (iDerm)

csymanzik@uos.de0541 9696 2357

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026